What Researchers Did
Researchers conducted a review to analyze the efficacy and limitations of hyperbaric oxygen therapy (HBOT) in orthopaedic and rheumatologic patients.
What They Found
The review found insufficient evidence regarding HBOT's effectiveness for fracture healing or non-union. However, for fibromyalgia patients, HBOT led to beneficial brain activity changes, reducing pain and significantly decreasing analgesic medication consumption. Additionally, HBOT demonstrated anti-inflammatory and oxygenatory effects in patients with primary or secondary vasculitis.
What This Means for Canadian Patients
Canadian patients with fibromyalgia might experience reduced pain and decreased need for analgesic medications with hyperbaric oxygen therapy. However, for orthopaedic conditions like non-healing fractures, the evidence for HBOT's effectiveness is currently insufficient, meaning its use is not clearly supported.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor does it specifically address the Canadian healthcare context.
Study Limitations
A significant limitation is the controversial and often insufficient evidence regarding HBOT's efficacy for many orthopaedic conditions, highlighting the need for more robust research.